Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / KPTI - Karyopharm Therapeutics announces changes to its commercial leadership team

KPTI - Karyopharm Therapeutics announces changes to its commercial leadership team

Karyopharm Therapeutics Inc.
A commercial-stage pharmaceutical company pioneering novel cancer therapies, Karyopharm Therapeutics (KPTI) announces key management changes to its commercial organization.John Demaree, chief commercial officer, and Perry Monaco, Senior VP of Sales, will be leaving to pursue other opportunities.Appoints Sohanya Cheng, MBA, as Senior VP of Sales and Commercial Operations.Payman Darouian, PharmD, Senior VP of Marketing will lead all marketing activities for company's lead product  XPOVIO.The Company does not currently plan to fill the position of Chief Commercial Officer and both Ms. Cheng and Dr. Darouian will report directly to Richard Paulson, President and CEO.

For further details see:

Karyopharm Therapeutics announces changes to its commercial leadership team
Stock Information
Company Name: Karyopharm Therapeutics Inc.
Stock Symbol: KPTI
Market: NASDAQ
Website: karyopharm.com
Menu
KPTI KPTI Quote KPTI Short KPTI News KPTI Articles KPTI Message Board
Get KPTI Alerts

News, Short Squeeze, Breakout and More Instantly...